Rennes: Third Suspicious Case, 50+ Identified
- Rennes, France – Health officials are investigating a cluster of meningococcal meningitis cases in Rennes, prompting a vaccination campaign.
- A third possible case is also under investigation, according to BFMTV.
- One of the two hospitalized individuals had attended a party on Saturday, April 27.
Meningitis Cases Prompt Vaccination Campaign in Rennes
Table of Contents
Rennes, France – Health officials are investigating a cluster of meningococcal meningitis cases in Rennes, prompting a vaccination campaign. Two young adults, ages 16 and 19, were recently admitted to Rennes University Hospital and initially placed in intensive care after contracting acute meningitis, according to health officials this week.
A third possible case is also under investigation, according to BFMTV. The recent cluster has raised concerns in the Ille-et-Vilaine region.
One of the two hospitalized individuals had attended a party on Saturday, April 27. While it remains unconfirmed if the second patient also attended the same event, health authorities have identified approximately 50 potential contacts, according to the Regional Health Agency (ARS).
In a press release Friday, the ARS stated that one of the hospitalized patients has been moved out of intensive care but remains under medical supervision. The agency also noted that no new cases have been confirmed. Health insurance guidelines define close contacts as individuals having direct and prolonged contact (at least one hour) with the patients’ nasal or oral secretions within 10 days prior to hospitalization.
Brittany Vaccination Drive
France has seen an increase in invasive meningococcal infections (IIM), including those linked to serogroup B, during the 2024-2025 season, the ARS said. January saw a particularly high number of cases. Public Health France data indicates 95 cases were reported in January and 89 in February.
The Rennes metropolitan area, with nearly half a million residents, is particularly affected, according to the ARS. On March 3, the ARS of Brittany initiated a vaccination campaign targeting young people ages 15-24 who are students or educated in the Rennes area. Of the 100,000 individuals targeted, more than 64,000 have received at least one dose of the vaccine.
Meningococci, the bacteria responsible for these infections, are major causes of acute meningitis. Transmission primarily occurs through saliva droplets. While less transmissible than aerosols, close environments still pose a significant risk. The predominant meningococcal group circulating in Rennes is type B,but other groups,including C,W,and Y,are also present in France.
Meningitis Cases in Rennes: Your Questions Answered
This article provides information about a recent cluster of meningitis cases in Rennes, France, and the resulting vaccination campaign. It aims to answer your questions and provide you with a clear understanding of the situation.
What’s happening in Rennes regarding Meningitis?
Health officials in Rennes, France, are currently investigating a cluster of meningococcal meningitis cases. Two young adults, aged 16 and 19, were admitted to Rennes University Hospital and initially required intensive care. A third possible case is also under investigation.This recent cluster has raised concerns in the Ille-et-Vilaine region.
What is Meningitis?
Meningitis is an inflammation of the membranes (meninges) surrounding your brain and spinal cord. It can be caused by various factors, including bacterial infections, which are particularly concerning.
What type of meningitis is affecting Rennes?
The predominant meningococcal group circulating in Rennes is type B. Though, other groups, including C, W, and Y, are also present in France.
What are the symptoms of Meningitis?
While the article doesn’t go into the symptoms, if you suspect you or someone you know has meningitis, it’s essential to seek immediate medical attention. Common symptoms can include:
Sudden high fever
Severe headache
Stiff neck
Confusion
* Seizures
how is Meningitis Transmitted?
Meningitis is primarily transmitted through saliva droplets. Close environments pose a significant risk because of